Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 403 M454.9 M — Research & development —— — Operating income 39.5 M-34.7 M — Non-Operating Income, Total 64.4 M18.4 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 61.3 M19.1 M — Unusual income/expense 3.1 M-700 K — Pretax income 11.6 M-162.7 M — Equity in earnings 1.1 M600 K — Taxes 23.8 M34.2 M — Non-controlling/minority interest 1.9 M1.7 M — After tax other income/expense —— — Net income before discontinued operations -14.1 M-198.6 M — Discontinued operations 00 — Net income -14.1 M-198.6 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 14.1 M198.6 M — Basic earnings per share (Basic EPS) -140 K-0.7 — Diluted earnings per share (Diluted EPS) -140 K-0.7 — Average basic shares outstanding 100257.45 M — Diluted shares outstanding 100257.45 M — EBITDA 267 M210.7 M — EBIT 113.2 M43.8 M — Cost of revenue 449.2 M466.9 M — Other cost of goods sold 449.2 M466.9 M — Depreciation & amortization (cash flow) 153.8 M166.9 M —